Seems that the biggest complaint from the bashers is that
Seems that the biggest complaint from the bashers is that of the lack of information they have regarding blinded trials... You know who else doesn't like having trial locations and access to early data??? Competitors, trial manipulators etc... I do think there are entities that do not want IPIX to be successful. What I do not know is... is it a personal thing against Leo, he does seem to be the major focus of attacks or is competitor drug companies? Did Leo turn down a deal early and this is the response to not letting someone with money and stroke take a cheap one from him? It is pretty clear that the attacks on the other board have been geared to discrediting Leo. I personally think Leo has done a lot of goods things, but as an investor that has taken a large hit I would really like to see a deal to show the company has financial stability, and start working on other pipelines in the arsenal. I think we are close to the first deal(I hope we are close to the first deal).
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...
Continue Reading
Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...
Continue Reading
Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...
Continue Reading
Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...
Continue Reading
Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...
Continue Reading
